Registering Small Molecules and Biologics at Pfizer - An Update
BIOVIA and Pfizer presented together at BIOVIA Conference 2020, describing how BIOVIA’s Biological Registration and Chemical Registration products have been used to deliver a solution that enables Pfizer scientists to register small molecules and biologics. In this presentation, we will provide an update on enhancements made to the system since then. We’ll also touch on future direction and strategy in this area at Pfizer and look at ongoing developments with the BIOVIA Materials Registration solution. 2022 BIOVIA Conference
